Wed, Mar 4, 2015, 6:55 AM EST - U.S. Markets open in 2 hrs 35 mins


% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • zhanyong_1 zhanyong_1 Oct 19, 2012 7:40 AM Flag

    AEGR is in good cash position

    There last offering was on June 14, 2012. It was 3,400,000 shares of common stock at a price to the public of $14.75. This gave them a net proceeds of $47.3 million, after deducting underwriting discounts and commissions. This should last them more than a year, well into after FDA approval by the end of this year. The facts are all in their Website. Shorties are trying to create fear by lies, longs be aware.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • FDA advisers vote 13-2 that Aegerion data sufficient for approval. Experts all agreed that it makes FDA approval pretty much a sure thing. The company has prepared for the approval and the commercialization of their drug for a long time(see their quarterly report) and the sale would be immediate after approval. Cash flow could be quick and strong starting 3 months from now.

27.46+0.21(+0.77%)Mar 3 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.